LINCOLN PHARMACEUTICALS Q3 FY25 Results
LINCOLN PHARMACEUTICALS has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 146.55 Cr
- Quarter-on-Quarter (QoQ) Change: -9.09% (Previous Quarter: Rs. 161.21 Cr )
- Year-on-Year (YoY) Change: 0.07% (Same Quarter Last Year: Rs. 146.45 Cr )
Profitability Metrics
- Net Profit: Rs. 20.77 Cr
- QoQ Profit Change: -21.12% (Previous Quarter: Rs. 26.33 Cr )
- YoY Profit Change: -25.93% (Same Quarter Last Year: Rs. 28.04 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 10.37
- QoQ EPS Change: -21.14% (Previous Quarter: Rs. 13.15)
- YoY EPS Change: -25.93% (Same Quarter Last Year: Rs. 14.00)
Performance Summary
Mixed
LINCOLN PHARMACEUTICALS had a complex financial situation. Different parts of the business are performing differently, showing a changing market.
This analysis provides a snapshot of LINCOLN PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.